149 related articles for article (PubMed ID: 37307239)
21. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
[TBL] [Abstract][Full Text] [Related]
22. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
McCluggage WG; Chong AL; de Kock L; Foulkes WD
Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
[TBL] [Abstract][Full Text] [Related]
23. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Kim MS; Lee SH; Yoo NJ; Lee SH
Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
[No Abstract] [Full Text] [Related]
24. Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation.
Luke AM; Moroney JW; Snitchler A; Whiteway SL
J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):598-600. PubMed ID: 28502826
[TBL] [Abstract][Full Text] [Related]
25. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
26. [A family with a congenital DICER1 mutation].
Altaraihi M; Pedersen J; Rossing M; Gedes AM; Wadt K
Ugeskr Laeger; 2018 Jun; 180(25):. PubMed ID: 29938629
[TBL] [Abstract][Full Text] [Related]
27. An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.
McCluggage WG; Fu L; Mohler K; de Kock L; Sabbaghian N; Mindlin A; Stewart CJR; Gilks CB; Foulkes WD
Int J Gynecol Pathol; 2022 Jul; 41(4):349-355. PubMed ID: 34380971
[TBL] [Abstract][Full Text] [Related]
28. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
[TBL] [Abstract][Full Text] [Related]
29. A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter: a case report.
Rossing M; Gerdes AM; Juul A; Rechnitzer C; Rudnicki M; Nielsen FC; Vo Hansen T
J Med Case Rep; 2014 Apr; 8():112. PubMed ID: 24708902
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
31. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract][Full Text] [Related]
32. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.
Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA
Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771
[TBL] [Abstract][Full Text] [Related]
33. Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
Merideth MA; Harney LA; Vyas N; Bachi A; Carr AG; Hill DA; Dehner LP; Schultz KAP; Stewart DR; Stratton P
Gynecol Oncol; 2020 Mar; 156(3):647-653. PubMed ID: 31952842
[TBL] [Abstract][Full Text] [Related]
34. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract][Full Text] [Related]
35. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
36. Intronic Germline
Fraire CR; Mallinger PR; Hatton JN; Kim J; Dickens DS; Argenta PA; Milanovich S; Hartshorne T; Carey DJ; Haley JS; Urban G; Lee J; Hill DA; Stewart DR; Schultz KAP; Chen KS
JCO Precis Oncol; 2023 Sep; 7():e2300189. PubMed ID: 37883719
[TBL] [Abstract][Full Text] [Related]
37. Sertoli-Leydig cell tumor, thyroid follicular carcinoma and rhabdomyosarcoma of the uterine cervix in a prepubertal girl with pathogenic germline variant in DICER1 gene.
Karnak İ; Ceylan AC; Haliloğlu M; Özön A; Orhan D; Kutluk T
Turk J Pediatr; 2021; 63(3):500-505. PubMed ID: 34254496
[TBL] [Abstract][Full Text] [Related]
38. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
39. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
40. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
